U.S. appeals court ruling may clear barrier to generic OxyContin

(Reuters) - A federal appeals court ruled Monday that four patents related to Purdue Pharma's painkiller OxyContin are invalid, potentially bringing Teva Pharmaceutical Industries Ltd and others a step closer to introducing generic versions of the drug.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news